NDATOPICALSUSPENSION
Approved
Dec 1988
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5
Data completeness
4/8 — Partial
LOPROX (ciclopirox) by Eurofarma Laboratórios is protein synthesis inhibitors [moa]. Approved for onychomycosis, dermatomycoses, foot dermatoses. First approved in 1988.
Drug data last refreshed Yesterday
Mechanism of Action
Protein Synthesis Inhibitors
Indications (3)
Worked on LOPROX at Eurofarma Laboratórios? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.